CAS 1118567-05-7 appears in our catalog under these names: Bexagliflozin, Bexagliflozin 98%, Bexagliflozin, 99%, 99%, BEXAGLIFLOZIN, 99%. Offered by: TRC, TargetMol, GLPBio, Biosynth, Ambeed. Available pack sizes: 250mg, 1mg, 2mg, 5mg, 10mg, 25mg, 50mg, 100mg.
Bexagliflozin is a C-glycosyl comprising of beta-D-glucose in which the anomeric hydroxy group is replaced by a 4-chloro-3-({4-[2-(cyclopropyloxy)ethoxy]phenyl}methyl)phenyl group. It is a sodium-glucose co-transporter 2 (SGLT2) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It has a role as a hypoglycemic agent, an antihypertensive agent and a sodium-glucose transport protein subtype 2 inhibitor. It is a C-glycosyl compound, an aromatic ether, a diether, a member of cyclopropanes and a member of monochlorobenzenes.
Source: ChEBI
| Molecular formula | C24H29ClO7 |
|---|---|
| Molecular weight | 464.9 g/mol |
| IUPAC name | (2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-(2-cyclopropyloxyethoxy)phenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol |
| InChIKey | BTCRKOKVYTVOLU-SJSRKZJXSA-N |
| SMILES | C1CC1OCCOC2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)Cl |
Computed by PubChem (NCBI)